Synonym/Acronym
iron: Fe; iron-binding capacity and iron saturation: TIBC, Fe Sat; transferrin: siderophilin, TRF.
Rationale
To monitor and assess iron levels related to blood loss, dietary intake and metabolism, storage disorders, and replacement therapy. To assist in diagnosing types of anemia such as iron deficiency.
Patient Preparation
Instruct the patient to fast for at least 12 hr before specimen collection for iron or transferrin and, with medical direction, to refrain from taking iron-containing medicines before specimen collection. There are no food, fluid, activity, or medication restrictions unless by medical direction for the TIBC and iron saturation. Specimen collection for iron studies should be delayed for several days after blood transfusion. Protocols may vary among facilities.
Normal Findings
Method: Spectrophotometry for iron and TIBC; nephelometry for transferrin.
Iron | ||
---|---|---|
Age | Conventional Units | SI Units (Conventional Units × 0.179) |
Newborn | 100250 ug/dL | 17.944.8 micromol/L |
Infant | 40105 ug/dL | 7.218.8 micromol/L |
Child | 50120 ug/mL | 921.5 micromol/L |
11 yradult | ||
Male | 45182 ug/dL | 8.132.6 micromol/L |
Female | 28170 ug/dL | 530.4 micromol/L |
Values tend to decrease in older adults.
Test | Conventional Units | SI Units (Conventional Units × 0.179) |
---|---|---|
TIBC | 250450 mcg/dL | 4581 micromol/L |
Transferrin-iron saturation % | 20%50% | 20%50% |
Conventional Units | SI Units (Conventional Units × 0.01) | |
Transferrin (direct measurement) | 200360 mg/dL | 23.6 g/L |
Iron
Timely notification to the requesting health-care provider (HCP) of any critical findings and related symptoms is a role expectation of the professional nurse. A listing of these findings varies among facilities.
Intervention may include chelation therapy by administration of deferoxamine mesylate (Desferal).
(Study type: Blood collected in a gold-, red-, or red/gray-top tube; related body system: ) .
Iron plays a principal role in erythropoiesis, the formation and maturation of RBCs, and is required for Hgb synthesis. The human body contains between 4 and 5 g of iron, about 65% of which is present in hemoglobin and 3% of which is present in myoglobin, the oxygen storage protein found in skeletal and cardiac muscle. A small amount is also found in cellular enzymes that catalyze the oxidation and reduction of iron. Excess iron is stored in the liver and spleen as ferritin and hemosiderin. Any iron present in the serum is in transit between the alimentary tract, the bone marrow, and available iron storage forms. Sixty to seventy percent of the bodys iron is carried by its specific transport protein, transferrin. TIBC and transferrin are sometimes referred to interchangeably, even though other proteins carry iron and contribute to the TIBC. For additional information about stored iron, refer to the study titled Ferritin.
Transferrin is a glycoprotein formed in the liver. Its role is the transportation of iron obtained from dietary intake or RBC breakdown; normally, one-third of available transferrin is saturated. Inadequate transferrin levels can lead to impaired Hgb synthesis and anemia. Transferrin is subject to diurnal variation, and it is responsible for the variation in levels of serum iron throughout the day. Normally, iron enters the body by oral ingestion; only 10% is absorbed, but as much as 20% to 30% can be absorbed in patients with iron-deficiency anemia. Unbound iron is highly toxic, but there is generally an excess of transferrin available to prevent the buildup of unbound iron in the circulation. Iron overload is as clinically significant as iron deficiency. An example of acute iron overload is the accidental poisoning of children caused by excessive intake of iron-containing multivitamins. Chronic iron overload can occur in patients receiving serial therapeutic transfusions of RBCs over time for treatment of various cancers, hemoglobinopathies such as sickle cell anemia, the thalassemias, and other hemolytic anemias.
Other Considerations
Summary of the Relationship Between Serum Iron, TIBC, Transferrin, % Iron Saturation, and Ferritin in Select Circumstances | |||||
---|---|---|---|---|---|
Iron | TIBC | Transferrin | % Saturation | Ferritin (Stored Iron) | |
Iron-deficiency (anemia) | Decreased | Increased | Increased | Decreased | Decreased |
Chronic etiology (cancer, infection, liver disease) | Decreased | Decreased | Decreased | Normal | Normal/increased |
Hemolytic (anemia) | Increased | Normal/decreased | Normal/decreased | Increased | Increased |
Iron overload/hemochromatosis | Increased | Decreased | Decreased | Increased | Increased |
Iron overload/therapy/poisoning | Increased | Normal/decreased | Decreased | Increased | Normal |
Increased In
Iron
TIBC and Transferrin
Decreased In
Iron
TIBC and Transferrin
Potential Problems: Assessment & Nursing Diagnosis/Analysis
Problems | Signs and Symptoms | ||
---|---|---|---|
Bleeding (blood lossrelated to heavy menses, disease process with chronic blood loss [GI ulcer, malignancy], overuse of NSAIDs) | Altered level of consciousness, hypotension, increased heart rate, decreased Hgb and Hct, decreased serum iron, capillary refill greater than 3 sec, cool extremities, poor dietary selections | ||
Tissue perfusion (inadequate cerebral, peripheral, renalrelated to inadequate cellular oxygen associated with unhealthy RBCs secondary to iron deficiency) | Confusion, altered mental status, headaches, dizziness, visual disturbances, hypotension, cool extremities, capillary refill greater than 3 sec, weak pedal pulses, altered level of consciousness, decreased urine output |
Before the Study: Planning and Implementation
Teaching the Patient What to Expect
After the Study: Implementation & Evaluation Potential Nursing Actions
Treatment Considerations
Bleeding
Tissue Perfusion
Nutritional Considerations
Clinical Judgement
Follow-Up Evaluation and Desired Outcomes